Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @kdsimonetti
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @kdsimonetti
-
Karen Simonetti proslijedio/la je Tweet
Johnson & Johnson is working with the latest in technology in order to change the trajectory of human health. Join us and help us improve the health across the world, every day. Join Johnson & Johnson as the - Operations Manager - JLABS @ Washington, DC,https://bit.ly/31f34Oc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
So happy we could host this event on
#BellLetsTalkDay to discuss how startup founders can manage their own mental health, and can support those they lead. Such an open & vulnerable discussion thank you to the panelists!
https://twitter.com/JLABS/status/1222637518203453440 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Karen Simonetti proslijedio/la je Tweet
We celebrated the launch of the
@JLABS Instagram account this morning with the most Insta-worthy meal of them all - brunch!
Follow along to hear about our awesome #JLABSToronto residents + what our sites around the
are up to! #BestTeamEver http://instagram.com/JLABS pic.twitter.com/gNbOLO8TmzHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Did you hear?
@JLABS is now on INSTAGRAM!
More JLABS, more stories on our entrepreneurs, more photos of our
sites ETC. Also you may see @AFMesquire pop up every once in a while and who would want to miss moments like this?! Follow us now!http://instagram.com/JLABS#JLABSTorontopic.twitter.com/8uv2vRapgP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Need more JLABS?
#JLABS is now on Instagram! Follow us for trends, tips and hot takes on the latest in health innovation. http://www.instagram.com/JLABS pic.twitter.com/CGwVVGeHQKHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Attend in-person or via live stream!
https://twitter.com/JLABS/status/1202303832677597184 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
The
@JLABS @ Washington DC Children’s#QuickFireChallenge is now accepting ideas through 4/24/20 with the aim to impact pediatric oncology, pediatric surgical care, & influenza! Apply for up to $150K in grant funding, residency, & mentoringhttp://jlabs.tv/DCHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
#JLABSBay Alumnus,@AudentesTx, to be acquired by Astellas Pharma for $3B to accelerate the development of genetics medicines for rare neuromuscular diseases.#GeneTherapy https://jlabs.tv/Audentes3BHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Join us December 2nd at
#JLABS Toronto as we acknowledge#WorldAIDSDay with a screening of the award-winning documentary@5BFilm, + a keynote presentation from Hanneke Schuitemaker of@JanssenGlobal. Register here https://jlabs.tv/34S553j#makeHIVhistorypic.twitter.com/aRFJIne75yHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Woohoo!
#JLABSToronto company@ManninResearch has received a $10.1M grant from the Free State of Saxony, Germany
It's part of a multi-year $15.65M investment by Mannin into it’s German R&D operations, where they're developing therapeutics for glaucoma
https://jlabs.tv/2q0axlY Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Congratulations to
#JLABSShanghai company APRINOIA Therapeutics for the initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a novel diagnostic PET imaging tracer for the characterization of tau burden in Alzheimer’s Disease!https://jlabs.tv/34t0yVaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Passionate about helping healthcare startups succeed? We are too. Join our team as the Business Operations Sr. Lead at JLABS @ Washington, DC https://jlabs.tv/2rtgmsA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Calling all
#nurses! Do you have an idea with the potential to improve oncology care?
Apply at https://jlabs.tv/336BBx7 . #JNJ together with@OncologyNursing &@JNJInnovation will award the best idea(s) up to $100k in grant funding & mentoringpic.twitter.com/FW4Q0WCLeZHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
San Diego
San Francisco
South San Francisco
Boston
Lowell, MA
Houston
Toronto
NYC
Beerse
Shanghai
DC
#JLABS newest launchpad for innovation will open its doors in DC soon. Until then, join us for#JLABSDC programming: https://jlabs.tv/31XYF0w pic.twitter.com/NJYOeqPsvXHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
We are excited to welcome back Aqua Mergers + Acquisitions today for part 2 of their workshop on creating an exit strategy plan! They talked to over 30 startups and acquirers when researching and creating their workshop.
#JLABSToronto@JLABSpic.twitter.com/s5unn6u8hO – mjesto: JLabs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Congratulations
@winterlightlabs! Amazing news for one of our#JLABSToronto residents

https://twitter.com/winterlightlabs/status/1196429023003451395 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
DYK: More than 1.3 million men are diagnosed w prostate cancer each year.
#JLABSToronto has partnered with@OICR_news +@MovemberCA for our prostate cancer event on Nov 26.#Movember will be collecting donations. Attend to learn more about the disease: https://prostatecancer.splashthat.com/ pic.twitter.com/6jAxYkhx3f
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Johnson & Johnson is working with the latest in technology in order to change the trajectory of human health. Join us and help us improve the health across the world, every day. Join Johnson & Johnson as the Operations Manager, JLABS @ Washington, DC.https://bit.ly/378zPz1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Karen Simonetti proslijedio/la je Tweet
Congratulations to THREE JLABS companies (
@deepgenomics,@LocusBio &@mammothbiosci) that were included in@CNBC’s#Upstart100 list as the most promising start-ups to watch in 2019
#JLABSToronto#JLABSBayhttps://www.cnbc.com/2019/11/12/100-of-the-worlds-most-promising-start-ups-to-watch-in-2019.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.